| 000 | 01323 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250516012223.0 | ||
| 264 | 0 | _c20120619 | |
| 008 | 201206s 0 0 eng d | ||
| 022 | _a1097-9867 | ||
| 024 | 7 |
_a10.3109/10837450.2010.531739 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTan, Celil | |
| 245 | 0 | 0 |
_aDevelopment of sustained release formulation of an antithrombotic drug and application of Fuzzy logic. _h[electronic resource] |
| 260 |
_bPharmaceutical development and technology _c |
||
| 300 |
_a242-50 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood Coagulation _xdrug effects |
| 650 | 0 | 4 |
_aBlood Platelets _xdrug effects |
| 650 | 0 | 4 | _aClopidogrel |
| 650 | 0 | 4 |
_aDelayed-Action Preparations _xchemistry |
| 650 | 0 | 4 | _aFuzzy Logic |
| 650 | 0 | 4 | _aNeural Networks, Computer |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aProthrombin Time |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 |
_aTiclopidine _xadministration & dosage |
| 700 | 1 | _aDegim, İsmail Tuncer | |
| 773 | 0 |
_tPharmaceutical development and technology _gvol. 17 _gno. 2 _gp. 242-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/10837450.2010.531739 _zAvailable from publisher's website |
| 999 |
_c20360554 _d20360554 |
||